APPLICATION
ANDA085008
TYPE
ANDA
ORIGINAL APPROVAL
1977-04-20
LATEST ACTION
1982-05-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
FEMOGENDiscontinued
ESTROGENS, ESTERIFIED 1.25MG · TABLET · ORAL
Approval history
1982-05-17Manufacturing (CMC) · Supplement 2AP
1977-04-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.